DB
SHC icon

Dmitry Balyasny’s Sotera Health SHC Stock Holding History

Dmitry Balyasny’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-161,784
Closed -$2.85M – 3468
2025
Q4 		$2.85M Buy
+161,784
New +$2.68M ﹤0.01% 1697
2025
Q3 		– Sell
-60,626
Closed -$674K – 3418
2025
Q2 		$674K Buy
+60,626
New +$710K ﹤0.01% 2187
2024
Q2 		– Sell
-558,303
Closed -$6.71M – 3051
2024
Q1 		$6.71M Buy
558,303
+547,177
+4,918% +$8.14M 0.01% 1107
2023
Q4 		$187K Sell
11,126
-434,716
-98% -$6.16M ﹤0.01% 2327
2023
Q3 		$6.68M Buy
+445,842
New +$7.52M 0.01% 992
2023
Q1 		– Sell
-22,497
Closed -$187K – 3099
2022
Q4 		$187K Buy
+22,497
New +$168K ﹤0.01% 2147
2022
Q2 		– Sell
-181,096
Closed -$3.92M – 3135
2022
Q1 		$3.92M Buy
+181,096
New +$3.84M 0.01% 1058
2021
Q3 		– Sell
-1,494,065
Closed -$36.2M – 2376
2021
Q2 		$36.2M Sell
1,494,065
-615,588
-29% -$15.1M 0.17% 141
2021
Q1 		$52.7M Buy
2,109,653
+1,033,903
+96% +$27.3M 0.26% 83
2020
Q4 		$29.5M Buy
+1,075,750
New +$28.9M 0.16% 168

Other funds holding SHC

DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Warburg Pincus New York $187M AUM 34% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Dmitry Balyasny's SHC Position: Q1 2026 in Review

Dmitry Balyasny sold out of Sotera Health (SHC) in Q1 2026, closing a stake of 161,784 shares — an estimated $2.85M sold.

Dmitry Balyasny first reported a position in SHC in Q4 2020 and held it in 10 quarters. The position peaked at $52.7M in Q1 2021. 299 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Dmitry Balyasny reported no remaining Sotera Health position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 161,784 Sotera Health shares in Q1 2026, an estimated $2.85M.
  • Dmitry Balyasny first reported a position in Sotera Health in Q4 2020 and held it in 10 quarters.
  • Dmitry Balyasny's Sotera Health position peaked at $52.7M in Q1 2021.
  • 299 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.